Page last updated: 2024-10-20

taurine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

taurine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 1 studies

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, CC1
Chang, CB1
Liu, JY1
Basavappa, S1
Lim, PH1

Other Studies

1 other study available for taurine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
Effects of calcium, calmodulin, protein kinase C and protein tyrosine kinases on volume-activated taurine efflux in human erythroleukemia cells.
    Journal of cellular physiology, 2001, Volume: 189, Issue:3

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Biological Transport; Calcium; Calcium Channel Blocke

2001
chemdatabank.com